Fundz

USpharma Ltd. received a growth equity investment from 1315 Capital. The funding will help accelerate the development and commercialization of its pipeline and scale its operations.

PRIVATEJun 30, 2025

Round Type

Private Equity

Miami LakesManufacturingBiotechnologyHealth CarePharmaceutical

Investors

1315 Capital

Description

USpharma Ltd., based in Miami Lakes, FL, has secured a growth equity investment from 1315 Capital. Although the amount of the deal was not disclosed, the company plans to use the funds to accelerate its pipeline development and scale its operations. Led by CEO Manesh Dixit, USpharma focuses on innovative healthcare solutions. The funding marks a significant step in enhancing USpharma's growth trajectory.

Quick answer

USpharma Ltd raised an undisclosed amount in a Private Equity round, dated June 30, 2025. Investors: 1315 Capital. USpharma Ltd is based in Miami Lakes, Florida, United States.

How much did USpharma Ltd raise?
USpharma Ltd raised an undisclosed amount in a Private Equity round on June 30, 2025.
Who invested in USpharma Ltd?
1315 Capital is named as investors in this round.
What does USpharma Ltd do?
USpharma Ltd. is a pharmaceutical development and manufacturing company that specializes in commercializing new delivery platforms.
Where is USpharma Ltd based and how big is it?
USpharma Ltd is based in Miami Lakes, Florida, United States. Fundz records about 75 employees.
Who are the decision-makers at USpharma Ltd?
Fundz holds 1 contact at USpharma Ltd. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Pharmaceutical and Manufacturing around the same time

Companies in the same sectors as USpharma Ltd that raised within 45 days of this round, from Fundz verified event records.

  • Phlow raised $37M (Series C) on July 22, 2025.
  • Helus Pharma raised $50M on June 30, 2025.
  • Persist AI raised $12M (Series A) on May 19, 2025.
  • Retension Pharmaceuticals raised $15M (Series B) on August 6, 2025.
  • Silexion Therapeutics raised $3.6M on August 1, 2025.
  • IM Cannabis Corp raised $4.1M (Post-IPO Equity) on July 31, 2025.

Who to call at USpharma Ltd, and when

A new round usually means USpharma Ltd is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day USpharma Ltd raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at USpharma Ltd, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at USpharma Ltd. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

USpharma Ltd

Location

Miami Lakes, Florida, United States

About

USpharma Ltd. is a pharmaceutical development and manufacturing company that specializes in commercializing new delivery platforms. The company focuses on innovation, development, licensing, and commercialization of healthcare products. USpharma aims to deliver accessible solutions that improve health and wellness.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment USpharma Ltd raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for USpharma Ltd's next move

See what Strategic adds

USpharma Ltd raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.